Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 31 results for "dusa pharmaceuticals"

Sun Pharma - Ranbaxy merger to create US$ 4 billion Indian pha...

After the completion of the merger process of Ranbaxy Labs with the Rs. 16,000 crore Sun Pharma, the merged entity will stand up as the largest Indian pharmaceutical company in the country. The success of merger will depend on effectively resolving ... PharmaBiz, 1 day ago
Sun Pharma acquires Pharmalucence VC Circle, 1 week ago

U.S. Patents Awarded to Inventors in Massachusetts (June 30)

U (Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., June 30 -- The following federal patents were awarded to inventors in Massachusetts. *** Collegium Pharmaceutical Assigned Patent ...
 TMC Net3 weeks ago

Caliber ID Appoints William F. ODell to Board

Caliber Imaging & Diagnostics, formerly Lucid, Inc, has appointed William F. ODell to its board of directors, increasing the size of the board to nine members as the company restructures its global sales and marketing program. ODell previously ...
 Imaging Economics1 month ago

Echo Mails Letter To Stockholders

PHILADELPHIA As previously announced, the Platinum Group is a dissident stockholder group led by Platinum Management (NY) LLC that is pursuing a proxy contest to elect Shepard M. Goldberg to the Echo Board at Echo's 2014 Annual Meeting of ...
 Benzinga.com1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less